The Effect of Treatment With Basal Insulin Peglispro or Insulin Glargine on Insulin Sensitivity and the Effect of Prandial Insulin Lispro in Patients With Type 2 Diabetes Mellitus
Phase of Trial: Phase I
Latest Information Update: 03 Nov 2018
Price : $35 *
At a glance
- Drugs Insulin peglispro (Primary) ; Insulin glargine; Insulin lispro
- Indications Type 2 diabetes mellitus
- Focus Pharmacodynamics
- Sponsors Eli Lilly
- 24 Jun 2015 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov record.
- 11 Mar 2015 Status changed from recruiting to active, no longer recruiting as reported by ClinicalTrials.gov.
- 09 Feb 2015 Planned End Date changed from 1 Apr 2015 to 1 May 2015 as reported by ClinicalTrials.gov.